Evidence map›Paper›PMID 40531460›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Synthesis of Hybrid Peptide-Based Materials.

Xin Luan, Gang Wei

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xin LuanCollege of Chemistry and Chemical Engineering, Qingdao University, Qingdao, People's Republic of China.
Gang WeiCollege of Chemistry and Chemical Engineering, Qingdao University, Qingdao, People's Republic of China. weigroup@qdu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide nanomaterials are a class of materials characterized by high biocompatibility, excellent degradability, and unique biomimetic properties. Moreover, they feature tunable amino acid structures and sequences, allowing flexible design and customization. By appropriately adjusting external factors such as solvents, pH, and temperature, peptide molecules can self-assemble into nanostructures ranging from zero-dimensional to three-dimensional forms driven by non-covalent interactions. Through the modification of functional groups abundant on peptides, these molecules can combine with nanoparticles, drug molecules, 2D materials, and other entities to form hybrid peptide-based nanomaterials with specific functionalities, which hold significant potential for applications in medicine, biotechnology, and environmental science. In this chapter, we provide key information and details for the synthesis of various hybrid peptide-based nanomaterials, which could be useful for readers to understand the design principles and synthesis strategies.

Indexed as

Biocompatible MaterialsNanostructuresPeptidesNanoparticlesBiocompatible MaterialsPeptideshybrid nanomaterialsPeptide–drug nonjugatesPeptide nanofibersPeptide nanosheetsPeptides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.